Science & Enterprise subscription

Follow us on Twitter

  • Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were high… https://t.co/oLdLmHGz1M
    about 9 hours ago
  • New post on Science and Enterprise: Venture Funds, Mergers in A.I. Up Sharply in 2018 https://t.co/rimak87tjS #Science #Business
    about 9 hours ago
  • Wish it weren't needed, but ... https://t.co/SZAb2GO2vz
    about 3 days ago
  • The Edelman public relations agency released results of a survey earlier this month gauging the public's awareness… https://t.co/XaxxGJOYQl
    about 3 days ago
  • New post on Science and Enterprise: Infographic – Public, Tech Execs Differ on A.I. Use https://t.co/cvVj3IyCR0 #Science #Business
    about 3 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

UC-Berkeley to Get New Crispr Patent

U.S. Patent and Trademark Office

University of California in Berkeley will soon receive a new patent for its development of the genome editing process known as Crispr, the latest round in a years-long dispute. . . . → Read More: UC-Berkeley to Get New Crispr Patent

Patent Set for Long-Term Drug Capsules

Star-shaped drug delivery

Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities. . . . → Read More: Patent Set for Long-Term Drug Capsules

Company Formed to Advance Sickle Cell Gene Therapy

Sickle cell illustration

A Swiss medical technologies company and Cincinnati Children’s hospital in Ohio are starting a new enterprise to commercialize research on gene therapies for inherited blood disorders. . . . → Read More: Company Formed to Advance Sickle Cell Gene Therapy

Patents Awarded for Stem Cell Heart Disease Technologies

U.S. Patent and Trademark Office

A company developing treatments for heart disease using stem cells to regenerate healthy heart tissue received two new patents for techniques supporting its core processes. . . . → Read More: Patents Awarded for Stem Cell Heart Disease Technologies

Appeals Court Backs Broad Institute in Crispr Case

Crispr genome edits illustration

A U.S. appeals court supported the Broad Institute’s claims it invented a separate Crispr technology from University of California, affirming a previous U.S. patent office ruling. . . . → Read More: Appeals Court Backs Broad Institute in Crispr Case

Ultra-Sensitive Nanotech Robot Skin Receives Patent

ultra-sensitive robot skin

Inventors of a system of sensors packaged in a thin film received a patent for their work that enables robotic devices to better sense conditions in the nearby environment. . . . → Read More: Ultra-Sensitive Nanotech Robot Skin Receives Patent

UC-Berkeley Gains U.S. Crispr-Cas9 Patent

Editing DNA

University of California received a patent for its genome editing technology known as Crispr, with the most widely used editing enzyme called Cas9. . . . → Read More: UC-Berkeley Gains U.S. Crispr-Cas9 Patent

Patent Awarded for Nanoparticle Drug, Cannabis Delivery

A delivery technology for therapeutic compounds in nanoscale natural oil particles received a U.S. patent, which the company owning the technology says can be applied to drugs, nutritional supplements, and cannabis-based treatments. . . . → Read More: Patent Awarded for Nanoparticle Drug, Cannabis Delivery

Patents Awarded for Genetic Editing of CAR T-Cells

U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells

Biotech, Pharma Dominate U.S. Academic Patents

In 2016, patents on biotechnology, pharmaceuticals, and medical technologies accounted for 40 percent of all academic patents, with measurement technologies and organic chemistry each getting 7 percent of the total. . . . → Read More: Biotech, Pharma Dominate U.S. Academic Patents